Skip to main content
. 2025 Feb 19;11:e04. doi: 10.15420/cfr.2024.30

Table 4: Association of Laboratory-defined Haemolysis with On-device and 30-day Mortality.

On-device Mortality 30-day Mortality
OR [95% CI] p-value OR [95% CI] p-value
Laboratory haemolysis 0.605 [0.109–3.357] 0.565 2.181 [0.367–12.952] 0.391
Origin of cardiogenic shock 1.288 [0.295–5.628] 0.736 0.821 [0.185–3.638] 0.794
Emergency Impella insertion 2.347 [0.315–17.467] 0.405 1.266 [0.212–7.552] 0.795
Lactic acid prior to device insertion 1.136 [0.940–1.371] 0.186 1.004 [0.838–1.203] 0.966
Pulse pressure variation 1.016 [0.983–1.050] 0.351 1.017 [0.983–1.051] 0.334
Left ventricular ejection fraction 0.973 [0.929–1.019] 0.244 0.973 [0.934–1.015] 0.205

Laboratory haemolysis defined as a drop in haemoglobin ≥2 g/dl and either undetectable haptoglobin or lactate dehydrogenase ≥250 units/l (twofold the upper limit of normal).